ESSI Takes the Lead: Dr. Vidali Presents on Deep Endometriosis Surgery & Advanced Adenomyosis Management at SEUD Conference in Puerto Rico
This week, the international spotlight shines on women’s health in Puerto Rico at the Society of Endometriosis and Uterine Disorders (SEUD) Congress. Endometriosis Surgical Specialists International (ESSI) is proud to announce that our own Dr. Andrea Vidali is a featured expert, sharing his unique, multidisciplinary approach on two of the most critical and complex topics in reproductive health: deep invasive endometriosis surgery and the modern management of adenomyosis in the context of IVF.
Dr. Vidali’s presence at this world-class forum underscores ESSI’s fundamental charter: providing world-class, multidisciplinary, and patient-centric care.
The Integrated Expertise of a World Leader
Dr. Vidali is a recognized world expert because his training extends far beyond general gynecology. He holds a powerful and rare trifecta of expertise that allows him to treat endometriosis and related conditions with unparalleled precision and insight:
-
Reproductive Endocrinologist (REI): He understands the intricate hormonal landscape and the delicate balance required for successful conception, making fertility preservation central to his surgical planning.
-
Reproductive Immunologist: He investigates how the immune system—often profoundly altered by endometriosis—affects egg quality, embryo implantation, and recurrent pregnancy loss.
-
Master Excision Surgeon: He specializes in meticulous, deep excision surgery to remove the disease at its root, including complex cases involving the bowel, bladder, and diaphragm.
This integrated knowledge allows ESSI to move beyond single-issue treatment, addressing the disease, its impact on pain, and its profound effect on fertility all at once.
Hot Topics: Deep Endometriosis & Advanced Adenomyosis Treatment
The two topics Dr. Vidali presented on are currently “hot” because they represent the most challenging aspects of the disease. In particular, his discussion on adenomyosis highlighted the promising role of minimally invasive, fertility-sparing techniques, including the use of Microwave Ablation (MWA).
| Complex Condition | Challenge Discussed at SEUD | ESSI’s Integrated & Advanced Solution |
| Deep Invasive Endometriosis | The high risk of recurrence and potential for multi-organ involvement (bowel, bladder). | Robotic Excision Surgery to fully remove all lesions while collaborating with co-surgeons to preserve vital organ function. |
| Adenomyosis & IVF | Adenomyosis (endometriosis in the uterine muscle) can severely compromise IVF success and lead to implantation failure. | Modern Management including fertility-sparing surgical techniques like Microwave Ablation (MWA) to optimize the uterine environment before an IVF cycle. |
Dr. Vidali is spearheading the use of Microwave Ablation for focal adenomyosis because it is a minimally invasive procedure that selectively destroys the localized adenomyotic tissue with heat. This approach preserves the integrity of the healthy surrounding uterine muscle, a critical factor for successful pregnancy outcomes in patients pursuing In Vitro Fertilization (IVF).
He emphasized that for patients with deep endometriosis and co-existing adenomyosis, successful treatment requires a coordinated, simultaneous approach—not treating the conditions sequentially.
By sharing these advanced surgical and reproductive strategies with a global audience of specialists, Dr. Vidali continues to lead the way in translating complex science into better clinical outcomes for endometriosis patients worldwide.
People Also Ask (PAA)
How does Microwave Ablation (MWA) help with adenomyosis?
MWA is a precise, minimally invasive technique that uses microwave energy to heat and destroy the specific areas of abnormal adenomyotic tissue deep within the uterine wall. This destruction of the focal lesions can reduce pain and heavy bleeding, and critically, it may improve the uterine environment and receptivity for embryo implantation during an IVF cycle by reducing inflammation and mass effect.
Is a 50% reduction in pain always a successful outcome?
While a 50% reduction is often used in clinical trials, it might not be a successful outcome for every patient. ESSI prioritizes the Minimal Clinically Important Difference (MCID), meaning our goal is not just a statistical decrease in pain but a change that allows you to meaningfully return to the activities you value, like work, exercise, and social life.
